Viewing data from:

FLUVASTATIN SODIUM

ANDA

FLUVASTATIN SODIUM | A078407 | TEVA PHARMACEUTICALS USA

2 strengths0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 4 NDCs

Highest NADAC/Unit

$3.08

per ea

Lowest NADAC/Unit

$2.87

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
00093744301FLUVASTATIN SODIUM 40 MG CAP	$3.08	EA	Generic	—	2026-06-17
00093744356FLUVASTATIN SODIUM 40 MG CAP	$3.08	EA	Generic	—	2026-06-17
00093744201FLUVASTATIN SODIUM 20 MG CAP	$2.87	EA	Generic	—	2026-06-17
00093744256FLUVASTATIN SODIUM 20 MG CAP	$2.87	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

VA Federal Supply Schedule

Government-negotiated contract prices | 2 NDCs (2 FSS)

Lowest Price

$381.63

Highest Price

$381.63

FSS NDCs

Big4 NDCs

Description	Price	Type	Vendor	Contract End
00093-7442-01FLUVASTATIN NA 20MG CAP	$381.63	FSS	AvKare, LLC	06/14/2028
00093-7443-01FLUVASTATIN NA 40MG CAP	$381.63	FSS	AvKare, LLC	06/14/2028

Source: VA Federal Supply Schedule (va.gov). Prices are government-negotiated contract prices.

API Supply Chain6 active DMFs5 inactive

4 active API suppliers hold Drug Master Files for this ingredient.

BIOCON LTDFLUVASTATIN SODIUM AMORPHOUS

DMF 184932005

BIOCON LTDFLUVASTATIN SODIUM

DMF 187622005

FIS FABBRICA ITALIANA SINTETICI SPAFLUVASTATIN SODIUM HYDRATE USP

DMF 189112005

TAPI NL BVFLUVASTATIN SODIUM

DMF 192962006

PHARMATHEN INDUSTRIAL SAFLUVASTATIN SODIUM AMORPHOUS

DMF 240912010

BIOCON LTDFLUVASTATIN SODIUM

DMF 367352022

CADILA HEALTHCARE LTDInactiveFLUVASTATIN SODIUM

DMF 178792004

USV LTDInactiveFLUVASTATIN SODIUM USP

DMF 205282007

LUPIN LTDInactiveFLUVASTATIN SODIUM (MICRONIZED) USP

DMF 215092008

AUROBINDO PHARMA LTDInactiveFLUVASTATIN SODIUM USP (NON-STERILE DRUG SUBSTANCE)

DMF 236572010

ZHEJIANG HISUN PHARMACEUTICAL CO LTDInactiveFLUVASTATIN SODIUM USP

DMF 259922012

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (2)

Sort:

#001 — EQ 20MG BASE

0 patents0 exclusivities▴

CAPSULE;ORAL | Approved: Jun 12, 2012

No patent or exclusivity listings for this strength.

#002 — EQ 40MG BASE

0 patents0 exclusivities▾

CAPSULE;ORAL | Approved: Jun 12, 2012